Assessing Air Travel Safety in Neuromuscular Dystrophy: Standard Versus Prolonged High Altitude Simulation Tests
Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
To determine if a prolonged high altitude simulation test (HAST) lasting two hours,
identifies more patients at risk of respiratory failure than the standard HAST lasting 20
minutes, in patients with neuromuscular disease (NMD) and severe pulmonary restriction. To
evaluate the safety of supplemental oxygen administered in those with a positive HAST in the
NMD population.